钆塞酸二钠增强磁共振成像用于肝纤维化分期:系统评价与Meta分析
该系统评价与Meta分析检索2004年1月至2018年8月四个数据库共57项相关研究,发现对比增强指数(CEI)是较常用的参数,纳入6项研究进行合并分析。CEI在F1-2与F3-4之间差异有统计学意义;对≥F1、≥F2、≥F3期的合并敏感度分别为0.58、0.57、0.61,特异度分别为0.84、0.68、0.75,SROC曲线下面积分别为0.85、0.76、0.72。作者认为有证据支持使用CEI,但需要更大规模研究的更多证据。
要点
- CEI计算为肝细胞期肝-肌信号强度比与增强前肝-肌信号强度比之商(SIpost/SIpre)。
- CEI在F1-2与F3-4之间加权均数差有统计学显著差异。
- 对≥F1、≥F2、≥F3期,CEI的合并敏感度均偏低(0.57–0.61),特异度中等(0.68–0.84)。
核心结论
- 用于钆塞酸二钠增强MRI肝纤维化分期的方法学和参数多样,但CEI是相对常用的参数。
- 总体上有证据支持使用CEI,但需要更大规模研究的更多证据。
研究设计与样本
- 研究类型为系统评价与Meta分析,检索PubMed、Web of Science、Embase和MEDLINE数据库2004年1月至2018年8月的文献。
- 共57项相关研究,其中6项使用CEI的研究被纳入合并分析。
- 参考标准为肝纤维化分期F0(正常肝)、F1(轻度肝纤维化)、F2(中度肝纤维化)、F3和F4(进展期肝纤维化)。
诊断标准与关键数值
- CEI计算公式为SIpost/SIpre,其中SIpost和SIpre分别为肝细胞期和增强前图像的肝-肌信号强度比。
- 对≥F1期,合并敏感度0.58、特异度0.84、SROC曲线下面积0.85。
- 对≥F2期,合并敏感度0.57、特异度0.68、SROC曲线下面积0.76。
- 对≥F3期,合并敏感度0.61、特异度0.75、SROC曲线下面积0.72。
- 加权均数差比较显示F1-2与F3-4之间差异有统计学意义。
局限性
- 原文结论指出需要更大规模研究的更多证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To identify and evaluate the efficiency of the most commonly used parameters applied to gadoxetate disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) for liver fibrosis (LF) staging.
MATERIALS AND METHODS: Literature searches of PubMed, Web of Science, Embase, and MEDLINE databases from January 2004 to August 2018 were conducted. The applied parameters during imaging were noted and summarised. Studies using the most commonly used parameter were included. Extractive data were combined as pooled weighted mean difference (WMD) to determine the benefits in LF staging. The pooled sensitivity, specificity, and summary receiver operating characteristics (SROC) curve were calculated.
RESULTS: Among 57 relevant studies, the contrast enhancement index (CEI) was a relatively commonly used parameter. It was calculated as SIpost/SIpre, where SIpost and SIpre are the liver-to-muscle signal intensity ratios in the hepatocyte phase and pre-enhanced images, respectively. Six studies were included. F0 was regarded as normal liver, F1 as mild LF, F2 as moderate LF, and F3 and F4 as advanced LF. Comparisons of WMD revealed significant differences between F1-2 and F3-4. For stage ≥F1, the pooled sensitivity, specificity, and areas under SROC curve were 0.58, 0.84, and 0.85, respectively; the corresponding values for ≥F2 were 0.57, 0.68, and 0.76, while those for ≥F3 were 0.61, 0.75, and 0.72.
CONCLUSION: The methodology and parameters used for Gd-EOB-DTPA-enhanced MRI for LF staging are diverse, but the CEI was a relatively common parameter. Overall, there is evidence to support use of CEI, but more evidence from larger studies is needed.
引用
- Li X, Liu H, Wang R, et al. Gadoxetate-disodium-enhanced magnetic resonance imaging for liver fibrosis staging: a systematic review and meta-analysis. Clin Radiol. 2019. PMID: 31831141. doi:10.1016/j.crad.2019.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。